Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Betadex
2. Cyclo-epta-amylose
3. Cycloheptaamylose
4. Cyclomaltoheptaose
1. Betadex
2. Cycloheptaamylose
3. Cyclomaltoheptaose
4. Cycloheptaglucan
5. 7585-39-9
6. Kleptose
7. Cycloheptaglucosan
8. B-cyclodextrin
9. Beta-cycloamylose
10. Cycloheptapentylose
11. .beta.-cyclodextrin
12. Cyclodextrin B
13. Kleptose B
14. Rhodocap N
15. Ringdex B
16. Ringdex Bl
17. Beta-cd
18. Betacd
19. Oristar Bcd
20. Ringdex-b
21. Beta-cyclodextrine
22. Maltodecaose Dp10
23. Cyclodextrin, Beta-
24. Beta-schardinger Dextrin
25. Cavamax W7
26. Jv039jzz3a
27. Caraway
28. Schardinger Beta-dextrin
29. Beta-cyclodextrin, Homopolymer
30. Ins No.459
31. Chebi:495055
32. Ins-459
33. Nsc-269471
34. Nsc-314334
35. Ncgc00090771-01
36. E459
37. Dsstox_cid_358
38. E-459
39. Dsstox_rid_75536
40. Dsstox_gsid_20358
41. 37331-89-8
42. 79647-56-6
43. Bcd
44. Beta -cyclodextrin
45. Beta-cyclodextrins
46. Cas-7585-39-9
47. Dextrin, Beta-cyclo
48. Unii-jv039jzz3a
49. Ccris 651
50. Ss-cyclodextrin
51. Betadex [usan:inn:ban:nf]
52. 1dmb
53. 2zyn
54. Beta-cyclo-dextrin
55. Einecs 231-493-2
56. Mfcd00078139
57. Betadex (nf/inn)
58. Nsc 314334
59. Schardinger A-dextrin
60. 2y4s
61. 3ck8
62. 3m3r
63. Ai3-29233
64. Betadex [inn]
65. Betadex [ii]
66. Betadex [mart.]
67. Betadex [who-dd]
68. Bdbm11
69. Ec 231-493-2
70. Beta-cyclodextrin, >=97%
71. Schembl24215
72. Betadex [ep Monograph]
73. Chembl415690
74. Beta-cyclodextrin [fcc]
75. Dtxsid1020358
76. .beta.-cyclodextrin [mi]
77. Beta Cyclodextrin [usp-rs]
78. .beta.-cyclodextrin [fhfi]
79. Heptakis(hydroxymethyl)[?]tetradecol
80. Tox21_111017
81. Tox21_201006
82. Akos015900444
83. Tox21_111017_1
84. Db03995
85. Nsc 269471
86. Alfadex Impurity A [ep Impurity]
87. Ncgc00090771-02
88. Ncgc00090771-03
89. Ncgc00090771-04
90. Ncgc00258559-01
91. Hy-107201
92. Cs-0027620
93. C-9120
94. D02401
95. Q27077120
96. Betadex, European Pharmacopoeia (ep) Reference Standard
97. D047392000
98. Cycloheptakis-(1->4)-(.alpha.-d-glucopyranosyl)
99. Beta-cyclodextrin, Produced By Wacker Chemie Ag, Burghausen, Germany
100. Beta Cyclodextrin, United States Pharmacopeia (usp) Reference Standard
101. Beta-cyclodextrin, Powder, Bioreagent, Suitable For Cell Culture, >=97%
102. Beta-cyclodextrin, Pharmaceutical Secondary Standard; Certified Reference Material
103. Beta-cyclodextrin, Produced By Wacker Chemie Ag, Burghausen, Germany, >=95.0% (hplc)
104. Beta-cyclodextrin, Produced By Wacker Chemie Ag, Burghausen, Germany, Life Science, >=98.0% (hplc)
105. Wurcs=2.0/1,7,7/[a2122h-1a_1-5]/1-1-1-1-1-1-1/a1-g4_a4-b1_b4-c1_c4-d1_d4-e1_e4-f1_f4-g1
Molecular Weight | 1135.0 g/mol |
---|---|
Molecular Formula | C42H70O35 |
XLogP3 | -15 |
Hydrogen Bond Donor Count | 21 |
Hydrogen Bond Acceptor Count | 35 |
Rotatable Bond Count | 7 |
Exact Mass | 1134.3697639 g/mol |
Monoisotopic Mass | 1134.3697639 g/mol |
Topological Polar Surface Area | 554 Ų |
Heavy Atom Count | 77 |
Formal Charge | 0 |
Complexity | 1480 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 35 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Food Additives
Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. (See all compounds classified as Food Additives.)
Sequestering Agents
Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. (See all compounds classified as Sequestering Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9155
Submission : 1991-06-10
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14620
Submission : 1999-12-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15489
Submission : 2001-06-15
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8423
Submission : 1990-02-02
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7435
Submission : 1988-04-14
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9403
Submission : 1991-10-21
Status : Inactive
Type : IV
Registration Number : 227MF20001
Registrant's Address : 2033 Becker Drive, Suite 310 Lawrence, KS 66047 United States
Initial Date of Registration : 2015-08-31
Latest Date of Registration : --
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Beta-Cyclodextrin API manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Beta-Cyclodextrin API, including repackagers and relabelers. The FDA regulates Beta-Cyclodextrin API manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Beta-Cyclodextrin API API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Beta-Cyclodextrin API supplier is an individual or a company that provides Beta-Cyclodextrin API active pharmaceutical ingredient (API) or Beta-Cyclodextrin API finished formulations upon request. The Beta-Cyclodextrin API suppliers may include Beta-Cyclodextrin API API manufacturers, exporters, distributors and traders.
click here to find a list of Beta-Cyclodextrin API suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Beta-Cyclodextrin API DMF (Drug Master File) is a document detailing the whole manufacturing process of Beta-Cyclodextrin API active pharmaceutical ingredient (API) in detail. Different forms of Beta-Cyclodextrin API DMFs exist exist since differing nations have different regulations, such as Beta-Cyclodextrin API USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Beta-Cyclodextrin API DMF submitted to regulatory agencies in the US is known as a USDMF. Beta-Cyclodextrin API USDMF includes data on Beta-Cyclodextrin API's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Beta-Cyclodextrin API USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Beta-Cyclodextrin API suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Beta-Cyclodextrin API Drug Master File in Japan (Beta-Cyclodextrin API JDMF) empowers Beta-Cyclodextrin API API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Beta-Cyclodextrin API JDMF during the approval evaluation for pharmaceutical products. At the time of Beta-Cyclodextrin API JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Beta-Cyclodextrin API suppliers with JDMF on PharmaCompass.
Beta-Cyclodextrin API Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Beta-Cyclodextrin API GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Beta-Cyclodextrin API GMP manufacturer or Beta-Cyclodextrin API GMP API supplier for your needs.
A Beta-Cyclodextrin API CoA (Certificate of Analysis) is a formal document that attests to Beta-Cyclodextrin API's compliance with Beta-Cyclodextrin API specifications and serves as a tool for batch-level quality control.
Beta-Cyclodextrin API CoA mostly includes findings from lab analyses of a specific batch. For each Beta-Cyclodextrin API CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Beta-Cyclodextrin API may be tested according to a variety of international standards, such as European Pharmacopoeia (Beta-Cyclodextrin API EP), Beta-Cyclodextrin API JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Beta-Cyclodextrin API USP).
LOOKING FOR A SUPPLIER?